Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Sign up Log in

Eledon Pharmaceuticals, Inc. Director's Dealing 2021

Apr 20, 2021

33900_dirs_2021-04-20_01d46716-f4d5-45b8-a404-f5f1cf847322.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: Eledon Pharmaceuticals, Inc. (ELDN)
CIK: 0001404281
Period of Report: 2021-04-19

Reporting Person: Smith Bryan E. (See Remarks)

More from Eledon Pharmaceuticals, Inc.

Regulatory Filings 2026
May 1
Annual Report 2026
Apr 30
Major Shareholding Notification 2026
Mar 26
Regulatory Filings 2026
Mar 19
Major Shareholding Notification 2026
Feb 17
Director's Dealing 2026
Jan 16
Director's Dealing 2026
Jan 16
Director's Dealing 2026
Jan 16
Director's Dealing 2026
Jan 16
Director's Dealing 2026
Jan 16
View all filings →